4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-21-038980
Sr VP/Chief Commercial Officer bought 12,985 shares at an average $2.81 ($36,505)
- Sr VP/Chief Commercial Officer gave up 2,945 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-03-17 | Shares withheld for taxes | −2,945 | $3.22 | $9,483 | 148,814 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-04-16 | Purchase | +105 | $3.03 | $318 | 148,919 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-04-19 | Purchase | +105 | $3.04 | $319 | 149,024 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-04-20 | Purchase | +105 | $3.02 | $317 | 149,129 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-04-21 | Purchase | +105 | $2.97 | $312 | 149,234 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-04-22 | Purchase | +105 | $2.96 | $311 | 149,339 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-04-23 | Purchase | +105 | $2.99 | $314 | 149,444 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-04-26 | Purchase | +105 | $2.97 | $312 | 149,549 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-04-27 | Purchase | +105 | $2.94 | $309 | 149,654 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-04-28 | Purchase | +80 | $2.94 | $235 | 149,734 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-04-29 | Purchase | +105 | $2.89 | $303 | 149,839 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-04-30 | Purchase | +105 | $2.78 | $292 | 149,944 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-03 | Purchase | +105 | $2.66 | $279 | 150,049 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-04 | Purchase | +105 | $2.66 | $279 | 150,154 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-05 | Purchase | +105 | $2.73 | $287 | 150,259 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-06 | Purchase | +105 | $2.74 | $288 | 150,364 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-07 | Purchase | +105 | $2.73 | $287 | 150,469 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-10 | Purchase | +105 | $2.71 | $285 | 150,574 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-11 | Purchase | +105 | $2.68 | $281 | 150,679 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-12 | Purchase | +105 | $2.86 | $300 | 150,784 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-13 | Purchase | +105 | $2.88 | $302 | 150,889 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-14 | Purchase | +105 | $2.81 | $295 | 150,994 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-14 | Purchase | +5,000 | $2.77 | $13,850 | 155,994 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-17 | Purchase | +105 | $2.84 | $298 | 156,099 | D |
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-05-17 | Purchase | +5,700 | $2.83 | $16,131 | 161,799 | D |
| Derivatives | |||||||
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2021-03-17 | Grant or award · Options (right to buy) | +5,000 | 5,000 | D | ||
| Open-market purchases · 12,985 sh · avg $2.81 · $36,505 | |||||||
Loading xslF345X03/doc4.xml…